Developing drugs to
halt the progression of neurodegenerative disease.
Our platform for target and drug discovery combines two areas of unique expertise to find progression-related targets:
- Proprietary computational tools and techniques to derive new biological insights from small and sparse data sets
- Pioneering CNS stem-cell models that recapitulate “progression” in vitro to select targets and drive drug discovery